Cagrilintide × Licensed Peptides - Lab Test, February 2026
Test results
About this test
This HPLC-UV/VIS certificate of analysis confirms Cagrilintide 5mg from Licensed Peptides at >99.80% chromatographic purity. The analysis was conducted by Vanguard Laboratory on February 20, 2026, with a tested quantity of 5.59mg. Endotoxin testing via LAL method returned a PASS at <5.00 EU/mg, within the USP/FDA threshold of 5 EU/kg.
Cagrilintide is a long-acting amylin analogue researched for its role in appetite suppression, weight management, and metabolic regulation. A purity level exceeding 99.80% indicates high-grade synthesis with minimal impurities.
The full certificate of analysis is available for download on this page.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.